Ateganosine
AssetAlso THIO, 6-thio-dG, 6-thio-2'-deoxyguanosine, NSC-71261
Telomere-targeting agent that induces telomeric DNA damage in cancer cells
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- TERT
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Non-small cell lung cancer
Phase 3, globenewswire.com, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Evidence for its targets3
- Competitors12
- Aging relevance2
Every asset’s record: target, stage, trials and the evidence behind it.